Micro-entity Accounts - KANDELIA PHARMA LIMITED

KANDELIA PHARMA LIMITED Registered Number 11922541

	2025	2024
	£	£
Called up share capital not paid	-	-
Fixed Assets	2,024,818	2,024,818
Current Assets	313,420	255,923
Prepayments and accrued income	-	-
Creditors: amounts falling due within one year	(92,821)	(102,684)
Net current assets (liabilities)	220,599	153,239
Total assets less current liabilities	2,245,417	2,178,057
Creditors: amounts falling due after more than one year	(1,659,682)	(1,705,046)
Provisions for liabilities	0	0
Accruals and deferred income	(4,173)	(2,161)
Total net assets (liabilities)	581,562	470,850
Capital and reserves	581,562	470,850

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 August 2025

And signed on their behalf by:
Nishma Patel, Director

Footnotes:

Advances and credits
As at 30th April 2025 company's bank borrowings secured on all tangible and intangible assets of the company were £672020 (2024: £725376)